订阅小程序
旧版功能

Evaluation of the Efficacy and Safety of Nivolumab in the Second- or Later-Line Treatment of Patients with Locally Advanced/metastatic Non-Small Cell Lung Cancer in Türkiye: a Retrospective Multicenter Non-Interventional Registry Study.

Nuri Karadurmus,Muhammet Ali Kaplan,Mehmet Ali Nahit Sendur,Yuksel Urun,Umut Demirci,Saziye Burcak Karaca,Sabin Goktas Aydin,Musa Baris Aykan,Ahmet Bilici,Ahmet Sezer,Ulku Yilmaz,Huseyin Abali,Perran Fulden Yumuk,Serkan Degirmencioglu,Ahmet Demirkazik,Semra Paydas,Cem Mirili,Hande Turna,Aysegul Kargi,Mustafa Ozdogan,Deniz Can Guven,Mustafa Ozguroglu,Saadettin Kilickap

CURRENT MEDICAL RESEARCH AND OPINION（2024）

引用 0|浏览24
关键词
Nivolumab,non-small cell lung cancer,second-line therapy,efficacy,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要